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ABSTRACT
The universal N(6)-threonylcarbamoyladenosine
(t6A) modification at position 37 of ANN-decoding
tRNAs is central to translational fidelity. In bacte-
ria, t6A biosynthesis is catalyzed by the proteins
TsaB, TsaC/TsaC2, TsaD and TsaE. Despite intense
research, the molecular mechanisms underlying
t6A biosynthesis are poorly understood. Here, we
report biochemical and biophysical studies of the
t6A biosynthesis system from Thermotoga maritima.
Small angle X-ray scattering analysis reveals a sym-
metric 2:2 stoichiometric complex of TsaB and TsaD
(TsaB2D2), as well as 2:2:2 complex (TsaB2D2E2), in
which TsaB acts as a dimerization module, similar to
the role of Pcc1 in the archaeal system. The TsaB2D2
complex is the minimal platform for the binding of
one tRNA molecule, which can then accommodate
a single TsaE subunit. Kinetic data demonstrate
that TsaB2D2 alone, and a TsaB2D2E1 complex with
TsaE mutants deficient in adenosine triphosphatase
(ATPase) activity, can catalyze only a single cycle
of t6A synthesis, while gel shift experiments pro-
vide evidence that the role of TsaE-catalyzed ATP
hydrolysis occurs after the release of product tRNA.
Based on these results, we propose a model for t6A
biosynthesis in bacteria.
INTRODUCTION
N6-threonylcarbamoyladenosine (t6A) is a universally con-
served modified nucleoside found at position 37 in the an-
ticodon stem-loop of many tRNAs decoding ANN codons
(N is any nucleotide) in all domains of life (Figure 1). The
(t6A37) modification shapes the architecture of the anti-
codon stem-loop, a requisite step for accurate decoding of
mRNA codons (1,2), and is one of the few modifications
found in all domains of life (3,4). Genotypes that are defec-
tive in t6A37 modification exhibit an increased frequency of
frameshift events and inaccurate selection of start codons;
these outcomes severely impair normal cellular functions
resulting in pleiotropic phenotypes (3,5), neurodegenera-
tion in humans (6) and are implied in the renal-neurological
disease Galloway–Mowat syndrome (7). t6A biosynthesis
occurs in two steps: members of the TsaC/TsaC2 (formerly
named YrdC/Sua5) family, present in all three domains
of life (8,9), utilize L-threonine, bicarbonate and adeno-
sine triphosphate (ATP) to synthesize the unstable path-
way intermediate threonylcarbamoyl adenylate (TC-AMP)
(10). The threonylcarbamoyl (TC) moiety of TC-AMP is
then transferred onto A37 of the substrate tRNA by the
threonylcarbamoyl transfer (TCT) complex, composed of
TsaB, TsaD and TsaE in bacteria (Tsa proteins; e.g. YeaZ,
YgjD and YjeE in Escherichia coli (11); and YdiC, YdiE and
YdiB in Bacillus subtilis (10)), by the KEOPS complex (Ki-
nase, putative Endopeptidase and Other Proteins of Small
size) in archaea (12) and the cytosols of eukaryotes (13,14),
and by the TsaD ortholog Qri7 in mitochondria (15). The
TsaD/Kae1/Qri7 protein family is responsible for the catal-
ysis of the transfer reaction. The archaeal KEOPS complex
is a duplicated linear arrangement of four proteins Cgi121-
Bud32-Kae1-Pcc1-Pcc1-Kae1-Bud32-Cgi121 (16) whereas
the eukaryotic KEOPS complex (studied so far only in
yeast and human) is a linear complex of Gon7-Pcc1-Kae1-
Bud32-Cgi121 (17,18), and Qri7 is a quarantined dimer
(15).
The t6A biosynthesis pathway is essential in bacteria (an
exception is Streptococcus mutans (19)) and TsaE and TsaB
are bacterial specific, establishing these proteins as com-
pelling new targets for antimicrobial development. Further,
an essential interaction network between TsaB, TsaD and
TsaE in vivo has been well documented (20–22). In vitro
pull-down assays on the purified E. coli proteins showed
that TsaC forms complexes with either TsaD or TsaB, while
neither protein alone bound to TsaE (11). Later, the crys-
tal structures of the heterodimer of TsaD and TsaB from E.
coli (23) and Salmonella typhimurium (24) were determined,
and a 1:1:1 stoichiometric complex of E. coli TsaB, TsaD
and TsaE was isolated and its solution structure determined
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Figure 1. Location and structure of t6A37 in tRNA. (A) Schematic of the anticodon stem-loop of tRNANNU and the mRNA ANN codon it decodes. (B)
The chemical structure of t6A.
by small angle X-ray scattering (SAXS) (23). ATP-mediated
formation of this complex is reportedly required for t6A
biosynthesis on tRNA (23). In S. typhimurium, isothermal
titration calorimetry (ITC) experiments revealed ATP- and
adenosine diphosphate (ADP)-dependent binding of TsaE
to the TsaB/TsaD 1:1 complex, and an ATP dependent
binding of TsaE to TsaD (24). TsaE is an atypical ATPase
that hydrolyzes ATP to ADP only in the presence of TsaB
and TsaD (11), and this ATPase activity is necessary for cell
growth (25).
Although the subunit interactions in several bacterial t6A
biosynthesis systems have been elucidated, their exact roles
in the catalytic cycle and in recognition of the tRNA sub-
strate remain unknown. Furthermore, the contribution of
the hydrolysis of ATP by TsaE to the biosynthesis of t6A
in bacteria remains unclear. Here we present biophysical,
biochemical and kinetic studies of the structure and mecha-
nism of the Thermotoga maritima t6A biosynthesis system.
The results show that a larger subcomplex, formed by the
subunits TsaB and TsaD and possessing a dimeric structure,
is the tRNA binding scaffold and reveal the role of TsaE and
its ATPase activity to be needed after the turnover and dis-
sociation of the modified tRNA product.
MATERIALS AND METHODS
Cloning procedures
The T. maritima tsaD gene (NCBI accession number
WP 004082750) was synthesized by Genescript (www.
genescript.com) and cloned into the BamHI (5′-end)
and Xho1 (3′-end) sites of pET-45b (Novagen, San
Diego, CA) in-frame with a non-cleavable N-terminal
His6 tag. Clones of T. maritima tsaB (NCBI acces-
sion number WP 004080725), tsaC2 (NCBI accession
number AGL49779), and tsaE (NCBI accession number
AGL50565) in a pBAD vector were kindly provided by the
Joint Center for Structural Genomics (La Jolla, CA, (26))
and were subcloned into the NheI (5′-end) and HindIII
(3′-end) restriction sites of a pET-28a expression vector
(Novagen, San Diego, CA) in-frame with the N-terminal
His6 tag and a thrombin cleavage site. The nucleotide se-
quences of the resulting constructs, pET28a-tsaB, pET28a-
tsaC2, pET28a-tsaE and pET45B-tsaD, were confirmed by
sequencing (Genewiz, Inc., South Plainfield, NJ, USA) and
used for expression and purification. All primers used for
cloning are listed in Supplementary Table S1.
Single-site mutagenesis of T. maritima TsaE
Point mutagenesis was carried out on TsaE (cloned in pET-
28a) using the Q5® Site-Directed Mutagenesis Kit (NEW
ENGLAND Biolabs Inc.). The Glu108 residue was mu-
tated to Ala (GAA→GCA). Thr43 was mutated to Ala
(ACG→GCA). Primers used for the mutations are listed in
Supplementary Table S1. Resulting DNA constructs were
confirmed to be correct and in the frame by sequencing (at
Genewiz, Inc, South Plainfield, NJ, USA).
Protein expression and purification
All constructs of the T. maritima wild-type and mutant pro-
teins used in this study were expressed in E. coli Overex-
press™ C41 (DE3) cells (Lucigen Corporation, Middleton,
WI, USA). Cultures were grown in LB-Miller broth con-
taining kanamycin (50 g/ml) at 37◦C with shaking. Ex-
pression was induced at A600 = ∼0.6 by addition of iso-
propyl -d-1-thiogalactopyranoside (IPTG) to a final con-
centration of 0.5 mM, followed by 3–4 h of growth. Cells
were harvested by centrifugation at 6000 × g for 15 min at
4◦C, and the resulting cell pellets were suspended and lysed
in 40 ml of lysis buffer containing 50 mM Tris (pH 7.5),
100 mM NaCl, 10% glycerol and one cOmplete™ ULTRA
tablet of protease inhibitor cocktail (Roche Diagnostics, In-
dianapolis, IL, USA). The cell lysates were centrifuged at
20 000 × g for 30 min at 4◦C, and filtered using a 0.22 m
filter before being loaded onto a 5 ml Ni–NTA (Qiagen,
Valencia, CA, USA) column pre-equilibrated with binding
buffer containing 50 mM Tris (pH 7.5), 100 mM NaCl,
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10 mM imidazole and 1 mM -mercaptoethanol (BME)
(Buffer A). For purification of TsaC2 and TsaE, the col-
umn was washed with 25 ml of buffer A, followed by a
wash with 100 ml of wash buffer containing 50 mM Tris,
500 mM NaCl, 20 mM imidazole (pH 7.5) and 1 mM BME
(buffer B). The His6 tag was removed by thrombin diges-
tion (100 units) of the Ni-NTA-bound proteins for 10–16
h at 22◦C. For purification of TsaB and TsaD, the pro-
teins were eluted from the Ni-NTA resin with buffer A sup-
plemented with 300 mM imidazole after thorough wash-
ing with buffer B. For all proteins, elution fractions were
pooled and subjected to size-exclusion chromatography us-
ing a Sephacryl S-200 HR 16/60 column (GE Healthcare
Life Sciences, Pittsburgh, PA, USA) pre-equilibrated with
50 mM Tris (pH 7.5), 100 mM NaCl and 1 mM dithio-
threitol (DTT). For all proteins, purity of >95% was ver-
ified by sodium dodecyl sulphate-polyacrylamide gel elec-
trophoresis (SDS-PAGE). Escherichia coli TsaB, TsaD and
TsaE were overexpressed and purified as described previ-
ously (11).
Native gel migration assay
For native gel analysis of the interactions of T. maritima Tsa
proteins, protein combinations were mixed in a final vol-
ume of 20 l, with each protein component set at a final
concentration of 10 M, in buffer containing 25 mM Tris–
HCl (pH 7.5), 50 mM NaCl, 1 mM DTT and 5% glycerol.
A total of 20 l were loaded onto a 1.2% agarose gel, and
electrophoresed for 50 min at 135 mV on ice in a running
buffer composed of 30 mM Tris–HCl (pH 7.5) and 100 mM
glycine. Proteins were visualized on the gel by Coomassie
Blue staining.
Size exclusion chromatography
Gel filtration experiments were carried out using an En-
rich SEC 650 10 × 300 mm column (BIO-RAD, Hercules,
CA, USA) and an NGC chromatography system (Bio-Rad).
The column was calibrated as described in Supplementary
Methods. A total of 500 l of sample were loaded on the
column pre-equilibrated in buffer containing 50 mM Tris–
HCl (pH 7.5), 50 mM NaCl and 1 mm DTT and eluted us-
ing the same buffer at a flow rate of 0.25 ml/min, with de-
tection at 280 nm. A total of 1 mM ATP was included in the
buffer used for isolation of the protein heterocomplexes.
Small angle X-ray scattering (SAXS) data acquisition and
analysis
SAXS data were collected on the Bio-SAXS beamline
BL4–2 at the Stanford Synchrotron Research Laboratory
(27) using a Rayonix MX225-HE CCD detector (Rayonix,
Evanston, IL, USA) with a sample-to-detector distance of
1.7 m and a beam energy of 11 keV (λ = 1.127 Å). The mo-
mentum transfer (scattering vector) q was defined as q =
4 sin()/, where 2 is the scattering angle. The q scale
was calibrated by silver behenate powder diffraction (28).
All data were collected to a maximum q of 0.53 Å−1. For the
TsaB2D2 complex, scattering data were collected at a wave-
length of 1.3 Å for 10 consecutive 2-s exposures from a sam-
ple containing 1.1 mg/ml protein, 50 mM Tris (pH 7.5), 100
mM NaCl and 1 mM DTT. Scattering data were collected
from the buffer alone and subtracted from the total protein
solution scattering. For the TsaB2D2E2 complex, a 100 l
sample containing 20 M of each of TsaB and TsaD and 80
M TsaE was prepared in buffer containing 50 mM Tris–
HCl (pH 7.5), 100 mM NaCl, 1 mM DTT and 1 mM ATP;
and incubated for 30 min. The sample was loaded onto a
Superdex 200 PC 3.2/30 column (GE Healthcare Life Sci-
ences) pre-equilibrated in the same buffer. The protein was
eluted from the column at a flow rate of 0.05 ml/min and
passed through a 1.5-mm quartz capillary cell (Hampton
Research, Aliso Viejo, CA, USA) at 20◦C in line with the
X-ray beam. Scattering images were obtained with 1-s expo-
sures every 5 s using the data acquisition program Blu-ICE
(29,30). The data processing program SasTool (27) was used
for scaling, azimuthal integration and averaging of individ-
ual scattering images after inspection for any variations po-
tentially caused by radiation damage. The first 100 frames
were scaled and averaged to create a buffer-scattering pro-
file, which was then subtracted from each of the subsequent
images to produce the final scattering curve for each frame.
Data analysis was performed using tools in the ATSAS
package (31). Data for every five frames along the course
of the elution profile and free of signs of sample aggrega-
tion were averaged using PRIMUS (32). Radii of gyration
(Rg), extrapolated from the Guinier region of the Guinier
plot, were computed using PRIMUS (32). P(r) functions
were calculated using the program GNOM (33). Theoretical
scattering curves were computed from different structural
models and compared to experimental scattering curves us-
ing the program FoXS (34). The relative Porod volume was
determined from the SAXS data using DATPOROD, and
the molecular mass was determined using DATMOW (31)
and SAXS-MoW (HTTP://www.if.sc.usp.br/~saxs/). Nor-
mal mode analysis (NMA) was performed using the pro-
gram Sreflex (35) and conformational sampling and multi-
state modeling were executed in MultiFoXS (36). Ab initio
envelop reconstruction was performed using the programs
DAMMIN (37) and DAMAVER (38) in the ATSAS soft-
ware package (31). The structural parameters derived from
the SAXS data are summarized in Table 1.
3D homology modeling
Homology models of T. maritima TsaD and TsaE were
generated using the ModWeb server (https://modbase.
compbio.ucsf.edu/modweb/) (39), and any missing residues
were built using Modeller (40). To build a homology model
of the T. maritima TsaB2D2 stoichiometric complex, the
crystal structure of the T. maritima TsaB homodimer (form-
II) (41) was used as the core structure (after building any
missing residues in Modeller), and the positions of the two
TsaD subunits were determined based on the position of the
TsaD subunit in the crystal structure of the heterodimeric
complex of E. coli TsaD and TsaB (YgjD and YeaZ) (PDB
ID: 4YDU (23)) by superposing the TsaB subunit of the E.
coli complex onto each protomer of the crystal structure of
the T. maritima TsaB homodimer. Subsequently, two copies
of the monomeric homology model of T. maritima TsaD
were put in place of the E. coli TsaD subunits by superpo-
sitioning to yield the final TsaB2D2 model. To generate a
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Table 1. Parameters calculated from SAXS data
TsaB2D2 TsaB2D2E2
Structural parameters
Rg (Å) from Guinier plot 44.20 ± 0.06 48.22 ± 0.07
Rg (Å) from P(r) 44.86 ± 0.08 47.84 ± 0.1
Dmax (Å) 148.9 150
Porod volume estimate, Vp (Å3) 250,783 289,003
Molecular mass (kDa)
From DATMOW 129.22 158.85
From DAMMIN models 121.35 141.35
From theoretical protein sequence 128 166
Ab initio modeling parameters
DAMAVER NSD (averaged over 10 models)a 0.532 ± 0.142 0.69 ± 0.04
aNSD: normalized spatial discrepancy.
structural model of the TsaB2D2E2 stoichiometric complex,
two copies of the homology model of T. maritima TsaE were
docked onto the model of TsaB2D2 using ZDOCK (42).
Docking solutions were ranked based on chi values against
experimental SAXS data and electrostatic and surface com-
plementarity between each TsaE subunit and a concave sur-
face on the TsaB2D2 complex. However, during the course
of this study, we obtained crystals of the TsaB2D2E2 com-
plex and collected low resolution data (5 Å) and the pre-
liminary crystallographic electron density maps revealed a
more accurate orientation of the TsaE subunits in the com-
plex (Supplementary Figure S1). This information was used
to improve our homology model of TsaB2D2E2 which was
then used for fitting to the SAXS data. All structural align-
ments were performed in Coot (43) and structure figures
were prepared in PyMOL (Version 1.8 Schrödinger, LLC).
tRNA transcription and purification
Escherichia coli tRNAThrCGU and E. coli tRNALysUUU, used
for tRNA binding studies and radiochemical incorporation
assays, respectively, were produced by in vitro transcription
as detailed in Supplementary Methods.
Electrophoretic mobility shift assay for tRNA binding studies
The binding reactions were carried out in 10-l solutions
containing 17 nM (0.07 pmol) 32P-labeled E. coli tRNAThr,
0.25–10 M purified recombinant proteins or protein com-
plexes, 50 mM Tris–HCl (pH 7.5), 50 mM NaCl, 5 mM
MgCl2, 5% glycerol, 1 mM DTT, 0.1–0.5 mM ATP and
1 unit of RNasin®. For the tRNA and TsaE competition
assay, the binding reactions contained 5 M T. maritima
TsaB2D2 complex pre-incubated with 100 nM 32P-labeled
E. coli tRNAThr for 15 min, added 1–15 M T. maritima
TsaE and the same buffer conditions as above. For deter-
mination of the tRNA binding stoichiometry, the reactions
contained 25 M unlabeled E. coli tRNAThr, 100 nM 32P-
labeled E. coli tRNAThr and 6–75 M pre-isolated T. mar-
itima TsaB2D2 complex in the same buffer conditions as
above. Following incubation for 15 min at 4◦C, the reac-
tions were loaded onto a 10% non-denaturating polyacry-
lamide gel and electrophoresis was performed in 1× Tris-
Glycine-EDTA (TGE) buffer at 4◦C for 3 h at 7.5 V/cm.
The gels were autoradiographed to visualize the tRNA
and––when applicable––stained with Coomassie Blue to vi-
sualize the proteins. Band densities were measured using
Image Studio™ Lite 5.x (LI-COR Biotechnology, Lincoln,
NE, USA), and the density data were fit using the nonlinear
least squares method (44) in the program GraphPad Prism
version 7.00 (GraphPad Software, La Jolla California USA,
www.graphpad.com).
Enzymatic activity assays for formation of t6A-modified
tRNA (radiochemical incorporation assay)
Initial enzyme assays to test the ability of various T. mar-
itima Tsa proteins to synthesize t6A-modified tRNA were
performed in a volume of 50 l containing 100 mM Tris
(pH 8.0), 300 mM KCl, 5.0 mM DTT, 2 mM ATP, 20 mM
MgCl2, 20 M tRNALysUUU, 50 mM NaHCO3, 50 M L-
[U-14C]-threonine (100 000 DPM/assay) and 10 M TsaB,
TsaC2, TsaD and TsaE. Assays were incubated at 60◦C for
1 h, and the RNA was precipitated by the addition of 500
l 10% TCA and cooling on ice for at least 10 min. RNA
was then collected by filtration through Whatman GF/C
filters, and the filters were subsequently washed with 100%
cold ethanol. The dried filters were combined with Econo-
Safe scintillation cocktail (RPI™) and counted in a Hidex
300-SL liquid scintillation counter.
Enzyme time-course assays measuring the incorporation
of L-[14C]-threonine into RNA transcripts over time were
performed in a total volume of 225 l containing 100 mM
Tris (pH 7.5), 300 mM KCl, 5.0 mM DTT, 2 mM ATP,
20 mM MgCl2, 20 M tRNALysUUU, 50 mM NaHCO3,
250 M L-[14C]-threonine (4 500 000 DPM/assay), 4 M
each TsaB, TsaC2, and TsaD, and 2 M TsaE, TsaET42A,
or TsaEE108A (where appropriate). Assays were incubated at
37◦C for 2 h and 50 l aliquots were taken at 10, 30, 60 and
120 min. For assays with variable [TsaE], the TsaB, TsaC2,
TsaD proteins were present at 2 M each, and TsaE was
varied from 0.4 to 10 M. Assays were incubated at 37◦C
for 1 h and 50 l aliquots were taken at 10, 30 and 60 min.
RNA was precipitated and counted as described above.
Isothermal titration calorimetric (ITC) assay for protein-
protein and protein-nucleotide binding
ITC measurements of the thermodynamic parameters
of protein–protein and protein–ATP binding equilibria
were performed with a MicroCalITC200 instrument (GE
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Healthcare). For each measurement, a total of 20 injections
of 2 l of the injectant protein were performed at intervals
of 120 s under continuous stirring. Normalized area data in
kcal/mol of integrated peaks were plotted versus the mo-
lar ratio of injectant to sample titrated, using the Origin
7.0 software (OriginLab Corporation, Northampton, MA,
USA).
ATP binding measurements by MANT fluorescence
For qualitative assessment of the ability of wild-type T.
maritima TsaE and mutants TsaEE108A and TsaET42A
to bind ATP upon association with TsaB2D2, the flu-
orescently labeled , non-hydrolyzable ATP analog
2′/3′-O-(N-Methyl-anthraniloyl)-adenosine-5′-[(, )-
imido] triphosphate (MANT-AMPPNP) (Jena Bioscience,
Farmingdale, NY, USA) was employed. MANT-AMPPNP
was added to 200-l samples containing 1 M pre-isolated
TsaB2D2 and 1 M wild-type or mutant TsaE proteins
(thus forming the respective TsaB2D2E1 complexes) in
buffer containing 25 mM Tris (pH 7.6), 50 mM KCl and
2 mM MgCl2. Additionally, samples contained 1 M
TsaB2D2 and 2 M TsaE or mutant proteins (thus forming
the respective TsaB2D2E2 complexes). The final nucleotide
concentration was 0.1 M. Nucleotide binding was de-
tected by monitoring the increase in MANT fluorescence
(λex = 355 nm, λem = 448 nm), relative to its fluorescence in
the absence of proteins, using a Fluoromax-3 spectrofluo-
rimeter (Horiba Scientific, Edison, NJ, USA). As controls,
pre-isolated TsaB2D2 alone and individual proteins were
similarly tested in this assay.
TsaE ATPase activity assay
The ATP hydrolysis was carried out at 37◦C in 20-l reac-
tions containing 5 M wild-type or mutant TsaE with or
without an equimolar concentration of TsaB2D2, 49 M
ATP, 1 M [ -32P] ATP (PerkinElmer), 25 mM Tris (pH
7.6), 50 mM KCl and 2 mM MgCl2. The reactions were
stopped by the addition of 0.5 l of 10% SDS. The 2 l
of each reaction were spotted on a PEI–cellulose TLC plate
(Sigma-Aldrich) and radioactive nucleotides were separated
using 0.5 M KH2PO4 (pH 3.5) as solvent. Plates were dried,
and radioactivity was revealed by phosphorimaging.
Native PAGE analysis of t6A enzymatic assays
For native gel analysis of the interaction of product tRNA
with components of the T. maritima TCT complex, re-
actions were performed in a volume of 50 l and con-
tained 100 mM Tris (pH 7.5), 300 mM KCl, 5 mM DTT,
50 mM sodium bicarbonate, 20 mM MgCl2, 50 M [U-
14C]threonine (1 000 000 dpm), 2 mM ATP, 5% Glycerol,
8 M each TsaC2, TsaB, TsaD and 4 M either TsaE or
TsaEE108A where indicated. The tRNA concentration was
set at 40 M except in a single reaction with TsaB and TsaD,
in which case the tRNA concentration was at 3.5 M. Re-
actions were incubated at 37◦C for 1 h.
To obtain an independent sample of [14C]-labeled t6A-
modified tRNA, a 100 l reaction containing the compo-
nents above was carried out at 37◦C for 1 h. The assay
mixture was diluted to 400 l with water, and 40 l of
7.5 M ammonium acetate was added. A mixture of phe-
nol:chloroform:isoamyl alcohol (25:24:1; 440 l) was added
and, after vortexing, the aqueous layer was transferred to
900 l of cold 100% ethanol. The mixture was stored at
−20◦C for 30 min, subsequently centrifuged at 16 300 g for
30 min, the supernatant removed and the tRNA pellet re-
suspended in 50 l Tris–EDTA buffer (pH 7.5).
A 20 l aliquot of each reaction above, and a 5 l
aliquot of [14C]-labeled tRNA, were loaded onto a 10%
non-denaturing polyacrylamide gel and electrophoresis was
performed in 1× TGE buffer at 4◦C for 2 h at 10 mA. The
gel was fixed (40% methanol, 10% acetic acid) for 1 h and
exposed to a phosphorimager screen overnight. The screen
was scanned using a GE Healthcare Typhoon Trio Variable
Mode Imager Scanner, and the scan visualized using Image-
Quant TL.
RESULTS
Cloning of tsaB/C2/D/E genes from T. maritima and over-
production and purification of the recombinant proteins
The T. maritima tsa genes were obtained from the Joint
Center for Structural Genomics clone collection (26) and
sub-cloned into pET-28a or pET-45b vectors, with either a
cleavable (in the case of TsaB/C2/E) or non-cleavable (in
the case of TsaD) N-terminal His6 tag. Individual proteins
were overexpressed in E. coli and purified to homogeneity
by Ni-NTA and gel filtration chromatographies. The His6
tag was successfully cleaved from all proteins except TsaD.
Attempts to produce TsaD with a cleavable His6 tag failed
due to solubility problems (data not shown). Purity was ver-
ified by SDS-PAGE (Supplementary Figure S2A).
In vitro reconstitution of t6A37 forming activity of T. maritima
Tsa proteins
The in vitro formation of t6A37 by T. maritima TsaB, TsaC2,
TsaD and TsaE was probed using radiochemical-based as-
says in which the incorporation of [14C]threonine into the
RNA substrate was measured. As previously observed with
the E. coli t6A37 system (11), robust incorporation of ra-
dioactivity into the tRNA transcript was observed only in
assays containing all four proteins (Supplementary Figure
S2B).
Interactions of T. maritima Tsa proteins and isolation of sta-
ble TsaB2D2E1 and TsaB2D2E2 complexes
To investigate the interactions between the four Tsa proteins
of T. maritima, we analyzed their equimolar binary, ternary
and quaternary mixtures by native agarose gel electrophore-
sis (Figure 2A). The results show formation of a TsaB/TsaD
complex (Figure 2A, lane 6) and a TsaB/TsaD/TsaE com-
plex (Figure 2A, lane 12), as previously observed for the E.
coli (23) and S. typhimurium (24) orthologs. TsaE does not
interact with individual TsaB or TsaD proteins (Figure 2A,
lanes 7 and 10). However, TsaE forms a complex with TsaC2
as evidenced by almost complete disappearance of the TsaE
band, accompanied by narrowing of the TsaC2 band on the
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Figure 2. Identification and isolation of three stable complexes of Thermotoga maritima Tsa proteins. (A) Native agarose gel electrophoresis analysis
of individual T. maritima Tsa proteins (lanes 1–4) and various equimolar mixtures (lanes 5–15). (B) Size-exclusion chromatographic (SEC) profiles of
individual TsaB (gray dashed line) and TsaD (dotted line) proteins, of the TsaB2D2 complex (black dashed line) formed from an equimolar mixture of
TsaB and TsaD, of the TsaB2D2E1 complex (gray solid line) formed from an equimolar mixture of TsaB, TsaD and TsaE, and of the TsaB2D2E2 complex
(black solid line) formed by adding excess TsaE to an equimolar mixture of TsaB and TsaD. All SEC profiles were collected by monitoring absorbance at
280 nm. Inset: SDS-PAGE analysis of SEC fractions corresponding to the major SEC peaks for the protein mixtures.
gel (Figure 2A, lane 9). Further, the TsaE/TsaC2 hetero-
complex is formed even in the presence of TsaD (Figure 2A,
lane 13) or TsaB (Figure 2A, lane 14). Mixing of all four
proteins gives rise to a broad band with mobility spanning
that of the TsaB/TsaD, TsaB/TsaD/TsaE and TsaC2/TsaE
complexes (Figure 2A, lane 15), suggesting the presence of
all three complexes in the ternary mixture.
We then used size-exclusion chromatography to isolate
the different complexes observed by the gel shift assay. For
isolation of homocomplexes of individual proteins, no ATP
was included in the sample or chromatography buffer. For
isolation of heterocomplexes of mixed proteins, 1 mM ATP
was added to sample and buffer. Chromatography data con-
firm that TsaB and TsaD each elute as a homodimeric com-
plex with a homodimer molecular mass of 48 and 78 kDa,
respectively (Figure 2B), consistent with the known ho-
modimerization of the orthologs from E. coli (23), S. ty-
phimurium (45), Vibrio parahaemolyticus (46), Pseudomonas
aeruginosa (47) and with the crystallographically observed
homodimer of T. maritima TsaB itself (41). Upon equimo-
lar mixing of TsaB and TsaD, they form a complex with
an apparent mass of 120 kDa (Figure 2B), consistent with
a 2:2 stoichiometric complex (TsaB2D2). Chromatographic
analysis of an equimolar mixture of TsaB, TsaD and TsaE
in the presence of ATP yields a single peak correspond-
ing to an apparent molecular mass of 141 kDa, consis-
tent with a TsaB/TsaD/TsaE complex with a subunit sto-
ichiometry of 2:2:1 (TsaB2D2E1). However, when 1–3 mo-
lar excess of TsaE is included in the mixture, a larger, stable
TsaB/TsaD/TsaE complex can be isolated with an apparent
mass of 158 kDa, consistent with a subunit stoichiometry of
2:2:2 (TsaB2D2E2). SDS-PAGE analysis of the peak frac-
tions confirms the subunit contents and is consistent with
the deduced stoichiometries of the three complexes (Figure
2B and Supplementary Figure S3). Further, as previously
shown in the E. coli system (23), size-exclusion chromatog-
raphy demonstrates that TsaE does not bind to either TsaB
or TsaD homodimer (Supplementary Figure S4), indicating
that both TsaB and TsaD are necessary to create the TsaE
binding site (23).
To investigate whether the association of TsaE with
TsaB2D2 is ATP-mediated, as previously reported with the
E. coli (23) and S. typhimurium (24) systems, we measured
the affinity of TsaE to TsaB2D2 in the absence and presence
of nucleotides and MgCl2 by ITC. Titration of TsaE into
TsaB2D2, first in the absence of nucleotides then in the pres-
ence of ADP, resulted in binding with Kd = 1.3 ± 0.001 M
and 1.1 ± 0.1 M, respectively (Table 2 and Supplementary
Figure S5), whereas titration in the presence of 1 mM non-
hydrolyzable ATP analog AMPPCP and MgCl2 yielded a
Kd of 0.34 ± 0.07 M. These results show that, unlike the
E. coli and S. typhimurium systems, T. maritima TsaE is able
to bind to TsaB2D2 in the absence of nucleotides, although
affinity is enhanced approximately 4-fold in the presence of
ATP but not in the presence of ADP.
SAXS structure of TsaB2D2 reveals a symmetric dimer of het-
erodimers with flexible inter-subunit interfaces
To confirm the stoichiometries and obtain structural data
of the complexes in solution, we performed SAXS exper-
iments on the TsaB2D2 and TsaB2D2E2 complexes puri-
fied by gel filtration. Structural parameters derived from the
SAXS data are listed in Table 1. For the TsaB2D2 complex,
theoretical scattering curves and intra-particle distance dis-
tribution functions (P(r)) were calculated from 3D homol-
ogy models representing hypothetical 1:1, 2:1 and 2:2 stoi-
chiometric complexes of TsaB and TsaD (generated as de-
scribed in ‘Materials and Methods’ section), and compared
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Table 2. The thermodynamic parameters measured by ITC for the association of TsaE and mutants to TsaB2D2
Titrant (M) Injectant (M) Stoichiometry (n) Kd (M) H (kcal/mol) S (kcal/mol/deg)
TsaB2D2 (20)a TsaE (400) 2.72 0.34 ± 0.07 7.44 ± 0.13 54.7
TsaB2D2 (20)b TsaE (400) 2.16 1.1 ± 0.1 1.54 ± 0.054 32.5
TsaB2D2 (20) TsaE (400) 2.11 1.3 ± 0.001 11.9 ± 0.072 67.2
TsaB2D2 (20)a TsaET42A (400) 2.0 1.1 ± 0.01 10.34 ± 0.14 62.2
TsaB2D2 (20) TsaET42A (400) 2.8 1.4 ± 0.001 8.0 ± 0.62 53.9
TsaB2D2 (20)a TsaEE108A (400) 1.91 2.4 ± 0.02 11.90 ± 0.17 65.9
TsaB2D2 (20) TsaEE108A (400) 2.9 1.1 ± 0.001 9.3 ± 0.38 59.1
ain the presence of 1 mM AMPPCP and MgCl2.
bin the presence of 1 mM ADP and MgCl2.
to the experimental scattering curve and P(r) function. Al-
though the TsaB2D2 homology model provides the best fit
to the experimental scattering data (χ = 5.6) (Figure 3A
and B), a loss of plateau in the Porod–Debye plot (Supple-
mentary Figure S6) and the discrepancy between the theo-
retical Rg (40.44 Å) and the experimental Rg (44.2 Å) sug-
gest structural plasticity in the TsaB2D2 complex in solu-
tion. We therefore tested if a weighted mixture of multiple
models better represents the solution scattering. NMA, fol-
lowed by conformational sampling and multistate modeling
resulted in a two-state model constituted of two conforma-
tions with a distribution of 80%:20%. This model provides
a significantly improved fit to the experimental scattering
data (χ = 2.6) and P(r) distribution (Figure 3A and B), as
well as a calculated model Rg of 43 Å, in agreement with
the experimental value. In this model, the TsaD subunits
are mobile and their interfaces with the TsaB subunits are
loose, as indicated by a marked difference between the two
observed conformations. The major conformer is an open
form of TsaB2D2, exhibiting a distance between the centers
of mass of the two TsaD subunits of 85 Å (Figure 3C). In
the minor conformer, which represents a closed form, this
distance is 60 Å. Ab initio shape reconstruction from the
SAXS data, using 10 independent models and without en-
forcing 2-fold symmetry, yielded an average model with a
reasonable normalized spatial discrepancy (NSD) of 0.532.
The NMA-optimized two-state model shows an excellent fit
to the ab initio molecular envelope (Figure 3D).
SAXS structure of TsaB2D2E2 complex and stabilizing effect
of the TsaE subunits
To study the structure of the TsaB2D2E2 complex in so-
lution, SAXS data were collected by employing an FPLC
gel filtration step coupled to the SAXS measurements. The
Porod volume and molecular mass deduced from the SAXS
data (Table 1) are consistent with a monodisperse sample.
Further, the experimental Dmax values for TsaB2D2E2 and
TsaB2D2 are approximately the same (∼150 Å), indicating
that the TsaB2D2E2 structure is not more extended than
that of TsaB2D2, consistent with TsaE binding at the in-
terface of TsaB and TsaD. NMA fitting results in a single
structural model representing a single conformation of the
TsaB2D2E2 complex. The theoretical scattering curve from
this model is in good agreement with the experimental scat-
tering curve (χ = 1.7, Figure 4A). At last, ab initio shape
reconstruction from the SAXS data, using 10 independent
models without enforcing the 2-fold symmetry of the com-
plex, resulted in an average model with NSD value of 0.69
± 0.04). The NMA-optimized model shows an excellent fit
to the ab initio molecular envelope (Figure 4B).
The TsaB2D2 complex constitutes the minimal platform for
tRNA binding
We conducted electrophoretic mobility shift experiments to
investigate the binding of individual TsaB, TsaC2, TsaD and
TsaE proteins and their complexes (pre-isolated by gel filtra-
tion) to 32P-labeled E. coli tRNAThr (we have shown above
that E. coli tRNA is a good substrate for the T. maritima
enzyme system). Using individual proteins, no nucleopro-
tein complexes could be detected on the gel, even at high
protein concentrations, but weak binding to TsaC2 was ob-
served (Supplementary Figure S7). Unlike the individual
proteins, the TsaB2D2 and TsaB2D2E1 complexes bound
tRNA with an apparent Kd of 1.3 ± 0.07 and 0.8 ± 0.02 M,
respectively (Figure 5A and B). In contrast, the TsaB2D2E2
complex did not bind tRNA. These data demonstrate that
TsaB2D2 is the minimal tRNA binding platform, and indi-
cate that binding of one TsaE subunit to the TsaB2D2 plat-
form maintains, if not slightly increases, its tRNA binding
affinity whereas binding of the second TsaE subunit abol-
ishes tRNA binding.
To investigate this phenomenon more quantitatively, we
performed a competition electrophoretic mobility shift as-
say (EMSA) experiment in which we probed the ability of
TsaE to displace bound tRNA from the TsaB2D2 complex,
by adding increasing concentrations of TsaE to TsaB2D2
that is pre-bound to 32P-labeled tRNA. tRNA and pro-
tein were visualized on the gel by autoradiography and
by Commassie staining, respectively. The results show that
tRNA remains protein-bound at molar ratios of TsaE to
TsaB2D2 below 2:1, i.e. at conditions under which only the
TsaB2D2E1 complex is formed (Figure 5C and D). tRNA is
rapidly displaced from the complex as the TsaE-to-TsaB2D2
molar ratio approaches 2:1, at which point all TsaE is se-
questered in the TsaB2D2E2 complex and all tRNA is un-
bound, with excess free TsaE appearing at higher concen-
trations (Figure 5C, lanes 11–14 on the Commassie-stained
gel). These results indicate that tRNA and TsaE occupy
the same site on TsaB2D2 or that their binding sites signifi-
cantly overlap. Notably, the fact that the fraction of bound
tRNA remains unchanged as the complex transitions from
TsaB2D2 to TsaB2D2E1 suggests that while the 2-fold struc-
tural symmetry of the TsaB2D2 complex, and the presence
of two TsaE binding sites on it (Figure 4), are consistent
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Figure 3. The SAXS solution structure of the TsaB2D2 complex. (A) Comparison of the solution scattering curve (black circles) and the theoretical
scattering curves calculated from various attempted models (colored lines), and associated chi values. (B) Comparison of the P(r) functions calculated from
the experimental data (black circles) and the theoretical scattering curves (colored lines), showing best fit to the two-state model. (C) Ribbon diagrams of
the two states of the TsaB2D2 complex in the two-state model. The TsaB and TsaD subunits are colored in two shades of blue and magenta, respectively.
The numbers in parentheses represent the relative abundances of the states in solution. The distanced between the centers of mass of the TsaD subunits
are shown. (D) Ab initio reconstruction of the molecular envelope of the TsaB2D2 complex (gray surface) calculated from the SAXS data and overlaid on
states I and II in magenta and yellow, respectively.
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Figure 4. The SAXS solution structure of the TsaB2D2E2 complex. (A) Comparison of the solution scattering data (black circles) to the theoretical
scattering curves calculated from various attempted structural models (colored lines). The chi values for the various models are listed. (B) The averaged
ab initio reconstruction of the TsaB2D2E2 molecular envelope calculated from the SAXS data and overlaid on the ribbon diagram of the NMA-optimized
model. The TsaB, TsaD and TsaE subunits are colored in two shades of blue, magenta and cyan, respectively. The distance between the centers of mass of
the two TsaD subunits is shown.
with two tRNA binding sites on TsaB2D2, the complex can
apparently accommodate only a single tRNA.
The observation that the T. maritima TsaB2D2E2 com-
plex does not bind tRNA is consistent with previous re-
ports of the orthologous, ternary complex from E. coli (E.
coli TsaB1D1E1) failing to bind tRNA (23). Thus, we pu-
rified the E. coli binary complex TsaB1D1 and the ternary
complex TsaB1D1E1 by gel filtration chromatography and
investigated their tRNA binding properties. As in the T.
maritima system, E. coli TsaB1D1 binds tRNA while the
TsaB1D1E1 complex does not (Supplementary Figure S8),
indicating conserved modes of binding of the TsaE subunit
and of tRNA, and suggesting a conserved role of these in-
teractions in the catalytic mechanism.
A single tRNA molecule binds in one of two equivalent sites
on the TsaB2D2 platform
Given the results of the competitive EMSA experiment
(Figure 5C and D), we conducted a gel mobility shift ex-
periment using conditions where the tRNA concentration
was ∼20-fold greater than the Kd in order to unambiguously
determine the stoichiometry of tRNA binding to TsaB2D2.
In this experiment, the pre-isolated TsaB2D2 complex was
titrated into 32P-labeled tRNAThr, and the molar equivalent
of protein necessary to saturate binding was determined by
plotting the fraction of bound radiolabeled tRNA as a func-
tion of molar equivalents of protein to tRNA. The results
clearly show saturation occurring at a tRNA-to-TsaB2D2
molar ratio of 1:1 (Figure 6), indicating that although two
equivalent sites are available for tRNA binding on TsaB2D2,
only one site can be filled at a time, indicating half-site re-
activity.
TsaB2D2 alone can catalyze a single turnover of t6A biosyn-
thesis
The ability of tRNA to bind to TsaB2D2 as well as
TsaB2D2E1, the fact that TsaD harbors the active-site re-
sponsible for the conversion of TC-AMP and tRNA to t6A-
modified tRNA, and the observation that t6A activity as-
says in the absence of TsaE consistently exhibited higher
DPM’s than those lacking any of the other three proteins
(Supplementary Figure S2B), prompted us to investigate
more closely the role and necessity of TsaE in t6A forma-
tion.
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Figure 5. Binding of tRNAThr by the TsaB homodimer, TsaD homodimer, TsaE and pre-isolated complexes. Proteins were incubated with 100 nM of 32P-
labeled tRNAThr at room temperature and the mixtures separated by native PAGE (see ‘Materials and Methods’ section). (A) Autoradiograms showing
unbound tRNAThr (at the bottom of each gel) and the nucleoprotein complexes (at the top of each gel). (B) Plot of fraction of tRNA bound quantified
by densitometry as the ratio of upper-band intensity to total intensity in each lane. (C) TsaE-dependent release of tRNA from the TsaB2D2 complex.
TsaB2D2 complex (5 M) pre-incubated with 32P-labeled tRNAThr (100 nM) at room temperature was titrated with increasing concentrations of TsaE,
and analyzed by native PAGE. Top panel: autoradiogram of the native gel showing free and bound tRNA at the bottom and top of the gel, respectively.
Bottom panel: coomassie staining of the same gel. TsaE concentrations are indicated at the top, and lane numbers are indicated at the bottom. (D)
Densitometric quantification of the radioactive bands in panel A, n = 2.
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Figure 6. Stoichiometry of tRNA binding to TsaB2D2. (A) EMSA gel showing band shift corresponding to the TsaB2D2/tRNA complex with increasing
molar equivalents of TsaB2D2. (B) Plot of fraction of tRNA bound quantified as the ratio of upper-band density to total density in each lane, as a function
of the molar equivalents of the protein incubated with tRNA.
Inspection of our t6A assay data suggested that the ab-
sence of TsaE might result in a low level of activity, there-
fore we carried out t6A assays in the presence and absence
of TsaE at higher substrate concentrations and longer times
to better detect low levels of activity. The results (Figure 7A)
show that while assays containing the TsaB2D2E1 complex
result in robust activity with essentially complete conversion
of substrate tRNA to t6A-modified tRNA, assays lacking
TsaE produce t6A-modified tRNA up to but never exceed-
ing the concentration of TsaB2D2, indicating that TsaB2D2
alone can only catalyze a single turnover. The rate of t6A
formation by TsaB2D2 is also noticeably slower, with an
initial velocity ∼3.5× lower than TsaB2D2E1-catalyzed t6A
formation.
The ATPase activity of TsaE is necessary for multiple
turnovers
Given that TsaE exhibits robust ATPase activity (producing
ADP and Pi) in the presence of TsaB and TsaD, we sought
to determine whether this activity was coupled to the abil-
ity of TsaE to support multiple turnovers by TsaB2D2. To
test this proposal, we constructed two active-site mutants
of TsaE (TsaET42A and TsaEE108A) that are capable of bind-
ing to TsaB2D2 (Figure 7B and Supplementary Figure S9)
but are deficient in ATP binding (Supplementary Figure
S10) and hydrolysis (Figure 7C), and examined the ability of
these mutants to support multiple turnovers in t6A assays.
The results clearly show (Figure 7D) that the loss of AT-
Pase activity in the mutant TsaE proteins is accompanied
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Figure 7. TsaE is required for multiple turnover of the t6A biosynthesis reaction. (A) Standard radiochemical t6A assays measuring the incorporation
of [14C]-threonine into tRNA. Assays contained Thermotoga maritima TsaC2 together with TsaB, TsaD and TsaE (open squares) or TsaB and TsaD
(filled squares). (B) Native agarose gel-shift analysis showing the association of wild-type TsaE and mutants TsaEE108A and TsaET42A with TsaB2D2
in the absence of nucleotides. (C) TLC radiogram of the ATP hydrolysis reactions (generating ADP and Pi) catalyzed by wild-type TsaE, and mutants
TsaEE108A and TsaET42A, in the absence and presence of TsaB2D2. [ -32P] ATP and the radiolabeled hydrolysis product  -phosphate are indicated. (D)
Standard radiochemical t6A assays measuring the incorporation of [14C]-threonine into tRNA. Assays contained T. maritima TsaC2, TsaB and TsaD either
alone (filled squares), or with added TsaEE108A (open squares) or TsaET42A (open triangles). (E) Radiochemical t6A assays ([14C]threonine) analyzed by
native PAGE. Reaction assays were carried out as described in the ‘Materials and Methods’ section, and contained 8 M each of TsaC2, TsaB and TsaD
([TsaB2D2] therefore 4 M). The [tRNA] in assays analyzed in lanes 1, 3 and 5 was 40 M, while the [tRNA] in the assay analyzed in lane 4 was 3.75
M. Lane 1. Standard assay (assay contains TsaB, TsaD and TsaE). Lane 2. Control lane––assay lacking tRNA. Lane 3. Assay contains TsaB and TsaD.
Lane 4. Assay contains TsaB and TsaD (low tRNA). Lane 5. Assay contains TsaB, TsaD and TsaEE108A. Lane 6. Control lane––[14C]-labeled t6A-modified
tRNA.
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by an inability to support multiple turnovers in t6A enzyme
activity assays.
To probe the timing of TsaE’s involvement in the reac-
tion cycle, in particular whether it was required for the re-
lease of the t6A-modified product tRNA from TsaB2D2 or
for a step after dissociation of product tRNA, we analyzed
standard radiochemical activity assays via EMSA (Figure
7E). In these experiments the product t6A-modified tRNA
becomes labeled with [14C]threonine, and can then be visu-
alized after gel electrophoresis by standard phosphorimag-
ing. As expected, in the assay containing all of the com-
ponents of the TCT complex (Figure 7E, lane 1) there is a
significant amount of t6A-modified tRNA produced, con-
sistent with multiple turnovers, with most of the product
tRNA migrating with the mobility of free tRNA (Figure
7E, lane 6) while a smaller amount of product tRNA can
be observed bound to the TsaB2D2 (or TsaB2D2E1) com-
plex (band near top of gel). When TsaE is absent (Figure
7E, lane 3), or a TsaE mutant deficient in ATP hydrolysis
(E108A) is included in the assay (Figure 7E, lane 5), much
less product is observed, consistent with the single turnover
behavior revealed above (Figure 7A and D). Notably, how-
ever, all of the product tRNA runs as free tRNA, not as
part of a TsaB2D2–tRNA complex, indicating that once
t6A-modified tRNA is formed it does not remain bound to
TsaB2D2, but freely dissociates from the TsaB2D2 complex.
In these assays the [tRNA] is 10× that of [TsaB2D2], so that
after a single turnover only a small fraction (≤0.1) of the to-
tal tRNA pool is [14C]-labeled t6A-modified product tRNA,
and therefore virtually all tRNA bound to TsaB2D2 is un-
labeled substrate tRNA. In contrast, when the [tRNA] is
less than [TsaB2D2] (Figure 7E, lane 5), [14C]-labeled t6A-
modified product tRNA represents the bulk of the total
tRNA (as in lane 1) and partitioning of labeled tRNA be-
tween free and bound states is observed. In the absence of
substrate tRNA (lane 2) there are no observable bands, con-
firming that all of the bands in the other lanes are due to
t6A-modified tRNA and not to any non-specific association
of [14C]threonine with assay components. A faint, diffuse
band is also observed in lane 1 of Figure 7E between the
band due to free tRNA and the TsaB2D2–tRNA complex,
and may represent binding of tRNA to TsaC2 as observed
above (Supplemental Figure S7).
Finally, the observation that TsaE binds to TsaB2D2 with
higher affinity in the presence of ATP than in the absence of
ATP (or the presence of ADP) suggested that t6A biosyn-
thesis might involve the cycling of TsaE between a bound
and unbound state with respect to TsaB2D2. To investigate
this, we carried out t6A assays at variable [TsaE] to deter-
mine the TsaE-concentration dependence of the rate of t6A
formation. The velocity data show a direct dependence on
[TsaE] (Supplementary Figure S11) over a 10-fold concen-
tration range, consistent with a mechanism in which TsaE
binds and dissociates during each catalytic cycle.
DISCUSSION
Species-specific architecture of the threonylcarbamoyl trans-
fer (TCT) complex
The architecture of T. maritima TsaB2D2E2 complex pre-
sented here highlights the remarkable diversity in the as-
sembly and quaternary architecture of the TCT complex
in various species (Figure 8A). Comparing among bacte-
ria, in E. coli, this complex exhibits the architecture of
a single heterotrimer TsaB1D1E1 (23), whereas in T. mar-
itima it is a dimer of heterotrimers. Similarly, the func-
tionally analogous eukaryotic KEOPS complex is repre-
sented by a linear Pcc1-Kae1-Bud32-Cgi121 heterotetramer
in yeast (capped on the Pcc1 side by the small subunit Gon7)
(18), whereas the archaeal KEOPS complex is a dimer
of Pcc1-Kae1-Bud32-Cgi121 heterotetramers (48). Notably,
the orthologous KEOPS complex in human is the LAGE3-
OSGEP-PRPK-TPRKB heterotetramer when capped on
the LAGE3 side by the Gon7 ortholog C14ORF142, and
a dimer of heterotetramers in the absence of C14ORF142
(17).
The larger assembly of the T. maritima TCT complex
is attributed to the unique homodimerization mode of the
TsaB subunit from this organism. Specifically, TsaB ho-
modimerizes in two forms (46); form 1, common to all
bacterial t6A systems studied to date (e.g. S. typhimurium
(45), E. coli (49), V. parahaemolyticus (46) and T. maritima
(41)), exhibits a hydrophobic helical interface and one of
its monomers is replaced by the TsaD subunit in the com-
plexes of T. maritima (Figures 3 and 4) and in the S. ty-
phimurium and E. coli TsaB/TsaD complexes (23,24), i.e.
the intersubunit interface in the heterocomplex mimics that
in the form-1 TsaB homodimer. The form-2 TsaB homod-
imer, observed so far only in T. maritima (41), exhibits a
different architecture in which the -strands from the two
TsaB subunits pack together in an anti-parallel manner to
form an extended -sheet, leaving the hydrophobic helical
surface to interact with TsaD (Figures 3 and 4). This form-
2 TsaB homodimer serves as the dimerization module in T.
maritima TsaB2D2 and TsaB2D2E2 complexes, resulting in
a dimer of heterodimers and heterotrimers, respectively. In
these structures, the TsaB homodimer mimics the Pcc1 ho-
modimer in the KEOPS complex in acting as a dimerization
module for the entire complex (Figure 8A) (16,48). There-
fore, although the form-1 TsaB homodimer is thought to
be the dominant form, our results show that the form-2 ho-
modimer is equally biologically relevant, at least in Ther-
motogae.
Docking model of tRNA onto the TsaB2D2 complex
We showed that the TsaB2D2 complex is the minimal tRNA
binding scaffold (Figure 5 and Supplementary Figure S7),
suggesting that the interface between TsaB and TsaD sub-
units is required for tRNA binding. The results also suggest
that TsaE and tRNA occupy the same or overlapping site(s)
on TsaB2D2. Consistent with these results, free docking of
tRNA onto the SAXS structural model of the TsaB2D2
complex using HADDOCK (50) resulted in a model in
which tRNA bound to a positively charged groove at the in-
terface between TsaB and TsaD, which in turn places the an-
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Figure 8. Architecture of the TCT complex and role of its subunits in tRNA recognition and catalysis. (A) Schematic comparison of the architectures
of the TCT complexes in Escherichia coli, Thermotoga maritima, Eukarya (yeast and human) and Archaea. The mitochondrial complex represented by a
minimal Qri7 homodimer is also shown. The orthologous subunits in the various complexes are shown in the same color. (B) Ribbon diagram (left) and
electrostatic surface representation (right) of the free-docking model of tRNA onto the T. maritima TsaB2D2 complex showing the positively charged,
putative tRNA binding groove at the TsaB/D interface. Protein subunits are colored as in panel A. (C) Proposed catalytic cycle of t6A biosynthesis in T.
maritima. Numbers represent the various complexes formed in the course of synthesis. Protein subunits are colored as in panel A. The red oval and green
circle represent TC-AMP and t6A, respectively. The cycle is shown beginning with the TsaB2D2 structure (1). TsaE binds to one half of the preformed
TsaB2D2 complex (2), while tRNA and TC-AMP bind to the other half (3 and 4) where transfer of TC to tRNA is catalyzed (5), releasing AMP and setting
the system in an inactive state (glow). Following release of product tRNA (6), ATP hydrolysis by TsaE resets the system to enter the next cycle.
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ticodon loop of tRNA in the active site of the TsaD subunit
(Figure 8B). This docking model shows tRNA occupying
the TsaE binding site, consistent with the mutually exclusive
binding of tRNA and TsaE observed by EMSA (Figure 5C
and D). Further, attempts to dock a second tRNA molecule
into the other TsaD subunit of TsaB2D2 resulted in severe
clashes with the acceptor stem of the first tRNA (data not
shown), consistent with a TsaB2D2-to-tRNA binding stoi-
chiometry of 1:1 as observed by EMSA.
Proposed model of the catalytic cycle of t6A biosynthesis in
bacteria
The ability of TsaB2D2 together with TsaC2 to catalyze a
single cycle of t6A synthesis (Figure 7A) indicates that nei-
ther the TsaE subunit itself nor its ATPase activity is re-
quired for the transfer of TC-AMP from the TsaC2 active
site to the TsaD active site, nor for the condensation of
TC-AMP with tRNA to form t6A. Furthermore, the obser-
vation that product t6A-modified tRNA dissociates freely
from the TsaB2D2 complex (Figure 7E) demonstrates that
TsaE is also not required for tRNA release. Thus, the role of
TsaE can be isolated to the post-reaction period, and sug-
gests that the TsaB2D2 complex is left in a catalytically inac-
tive state after formation of t6A-modified tRNA, and that
TsaE-mediated ATP hydrolysis is required to somehow ‘re-
set’ the complex for another round of catalysis.
It has been reported that a mutant E. coli TsaE with no
ATPase activity is still active in E. coli t6A biosynthesis (23).
Similarly, it was reported that a mixture of B. subtilis TsaB,
TsaD and TsaE can support the synthesis of t6A when pro-
vided with the isolated TC-AMP intermediate in the ab-
sence of ATP (10). These reports appear to be inconsistent
with the data provided here for the T. maritima system, and
may represent mechanistic differences in different bacterial
species. However, the lack of rigorous t6A quantification in
these cases combined with very low apparent turnover pre-
cludes us from determining the stoichiometry of product
formation, and given that the protein concentrations used
were reasonably high (2.5 and 5 M), it is possible that the
t6A produced in these studies represents a single turnover or
less, and the requirement for TsaE-catalyzed ATP hydroly-
sis a mechanistic feature conserved in all bacterial systems;
clarification of this issue awaits more detailed analysis of the
reaction cycles for these systems.
The mutually exclusive binding of TsaE and tRNA, and
the differential binding affinities of TsaE for TsaB2D2 (and
TsaB1D1 in E. coli (23)) in the presence and absence of ATP,
suggest that TsaE associates and dissociates in the course
of a single catalytic cycle. Furthermore, although two TC
transfer sites (TsaD) are present in TsaB2D2, only one prod-
uct tRNA is turned over by this complex, indicating that
TC transfer in one site renders the entire TsaB2D2 com-
plex, not just one half of it, inactivated. This suggests that
TsaE-catalyzed ATP hydrolysis in one half resets the en-
tire TsaB2D2 platform, and that there is communication be-
tween the two halves of the complex during the course of
t6A synthesis. Based on the data, we propose the follow-
ing model for the t6A catalytic cycle in thermotoga. First,
a single TsaE subunit (pre-bound to ATP) binds to the pre-
formed heterocomplex TsaB2D2 (Figure 8C, 1 and 2), fol-
lowed by tRNA binding (Figure 8C, 3). TsaC2 then binds,
either with preformed TC-AMP or prior to TC-AMP syn-
thesis, and delivers TC-AMP to the active site of the tRNA-
bound TsaD subunit (Figure 8C, 4), allowing transfer of TC
to tRNA (Figure 8C, 5). Following the formation of t6A, the
t6A-modified tRNA dissociates from the complex (Figure
8C, 6). Subsequent hydrolysis of the bound ATP resets the
system to the initial state, presumably by affecting a con-
formational change within the TsaB2D2 platform that oc-
curred as a consequence of t6A formation, followed by re-
lease of TsaE. The next cycle of t6A synthesis can commence
with the binding of TsaE bound to ATP.
There are several questions that remain unanswered by
the data presented here and by our proposed mechanism.
The observation that the initial velocity of t6A formation
is greater (∼3.5-fold) in the assays containing TsaE than
those without (Figure 7A) is surprising in light of the role
of TsaE after product release (Figure 7E). This may be re-
lated to the apparent stabilizing effect of TsaE as seen in the
TsaB2D2E2 complex (Figure 4) compared with the TsaB2D2
complex (Figure 3), coupled with the fact that in the absence
of TsaE, TsaB2D2 functions as a stoichiometric reagent, not
a catalyst; i.e. it is capable of only a single turnover and so
can be considered ‘inactivated’ after it undergoes a reac-
tion and thus is not available to catalyze another reaction.
However, it may also be related to the interaction of TsaE
with TsaC2 observed by native agarose (Figure 2), which
may foreshadow another, albeit nonessential, role for TsaE
in catalysis, distinct from the essential role associated with
its ATPase activity.
Related to the nuances of the role of TsaE is the question
of how TsaC2 interacts with the TCT complex, the timing of
TC-AMP synthesis and transfer, and how the timing of TC
transfer and TsaE-catalyzed ATP hydrolysis is controlled.
TsaC2 clearly interacts with several components of the TCT
complex (Figure 2A), as well as with tRNA (Supplemen-
tal Figure S7), but these interactions do not constitute the
strong interactions observable, for example, by gel filtration
chromatography, suggesting that they are transient. The de-
tails of these interactions, and their importance to the cat-
alytic cycle, remain unknown at this point.
At last, and perhaps most intriguing, is the nature of the
interactions between TsaB2D2 and TsaE associated with the
ATPase activity of TsaE. It was unexpected that TsaE would
function after product release, as opposed to in some way
facilitating TC transfer or tRNA turnover. The observa-
tion that it instead appears to induce structural changes in
TsaB2D2 is fascinating, and elucidating the full extent of
these interactions clearly is important to understanding this
modification process.
These questions and others are the subject of active inves-
tigation, the results of which will be reported in due course.
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